Skip to main content

The Canines-N-Kids Foundation is working to put an end to the cancers children and our canine best friends BOTH develop - devastating cancers including bone and brain cancer, lymphoma and leukemia.


Get Email Updates


LEARN MORE about Canines-N-Kids' mission and our programs. DOWNLOAD OUR BROCHURE

News & Events

Ulrike Szalay worked in biotech and oncology for many years and grew frustrated by the fact that there was relatively little focus on childhood and canine cancers relative to the attention paid to cancers in adult humans. Even after leaving the field, she couldn’t shake the feeling that more could and should be done for children and dogs with cancer. And in 2017, she did something about it.

Studying naturally occurring diseases and treatment in canine patients , from cancer to osteoarthritis, and perhaps even Lyme Disease can potentially benefit both pets and people.

OS Therapies, a research and clinical-stage biopharmaceutical company announced today the dosing of the "First Patient In" for its lead OST-HER2 (OST31-164) program in a potentially pivotal Phase IIb clinical trial. OST-HER2 has already received Fast-Track and Orphan Designation from the EMA and FDA. The nationwide open-label trial will enroll 39 to 45 Osteosarcoma patients whose cancer has metastasized to the lungs and has been surgically resected. OST-HER2 is targeting Osteosarcoma in children and young adults, and potentially other solid tumors.OST31-164 has previously received USDA provisional approval for treatment of Osteosarcoma in canines.


Canines-N-Kids Foundation is a recognized 501c3 public charity. Our Federal Tax ID is 81-2768684


Powered by Firespring